PT2729475E - Derivados do ácido carboxílico com um anel de oxazolo[4,5-d pirimidina - Google Patents
Derivados do ácido carboxílico com um anel de oxazolo[4,5-d pirimidina Download PDFInfo
- Publication number
- PT2729475E PT2729475E PT127355030T PT12735503T PT2729475E PT 2729475 E PT2729475 E PT 2729475E PT 127355030 T PT127355030 T PT 127355030T PT 12735503 T PT12735503 T PT 12735503T PT 2729475 E PT2729475 E PT 2729475E
- Authority
- PT
- Portugal
- Prior art keywords
- oxazolo
- carboxylic acid
- acid derivatives
- pyrimidine ring
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11305879 | 2011-07-07 | ||
| EP12305527 | 2012-05-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2729475E true PT2729475E (pt) | 2015-10-14 |
Family
ID=46514336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT127355030T PT2729475E (pt) | 2011-07-07 | 2012-07-06 | Derivados do ácido carboxílico com um anel de oxazolo[4,5-d pirimidina |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8735402B2 (pt) |
| EP (1) | EP2729475B8 (pt) |
| JP (1) | JP5913586B2 (pt) |
| KR (1) | KR20140061386A (pt) |
| CN (1) | CN103797015B (pt) |
| AU (1) | AU2012280208B2 (pt) |
| BR (1) | BR112014000078A2 (pt) |
| CA (1) | CA2841229C (pt) |
| DK (1) | DK2729475T3 (pt) |
| ES (1) | ES2547110T3 (pt) |
| HK (1) | HK1192237A1 (pt) |
| IL (1) | IL230313A (pt) |
| MX (1) | MX369847B (pt) |
| MY (1) | MY165099A (pt) |
| PT (1) | PT2729475E (pt) |
| RU (1) | RU2609003C2 (pt) |
| WO (1) | WO2013004828A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9321787B2 (en) | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3679682A (en) * | 1970-04-23 | 1972-07-25 | Fmc Corp | CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES |
| US7060697B2 (en) * | 2003-05-19 | 2006-06-13 | Irm Llc | Immunosuppressant compounds and compositions |
| US8530483B2 (en) * | 2008-05-30 | 2013-09-10 | Merck Sharp & Dohme Corp. | Substituted azabenzoxazoles |
| TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
| NZ590377A (en) | 2008-07-15 | 2011-11-25 | Sanofi Aventis | Oxazolopyrimidines as edg-1 receptor agonists |
| US8907093B2 (en) * | 2011-07-07 | 2014-12-09 | Sanofi | Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
-
2012
- 2012-06-25 US US13/532,305 patent/US8735402B2/en active Active
- 2012-07-06 KR KR1020147003228A patent/KR20140061386A/ko not_active Application Discontinuation
- 2012-07-06 CN CN201280043168.XA patent/CN103797015B/zh active Active
- 2012-07-06 EP EP12735503.0A patent/EP2729475B8/de active Active
- 2012-07-06 WO PCT/EP2012/063302 patent/WO2013004828A1/de active Application Filing
- 2012-07-06 RU RU2014104233A patent/RU2609003C2/ru not_active IP Right Cessation
- 2012-07-06 CA CA2841229A patent/CA2841229C/en not_active Expired - Fee Related
- 2012-07-06 PT PT127355030T patent/PT2729475E/pt unknown
- 2012-07-06 DK DK12735503.0T patent/DK2729475T3/en active
- 2012-07-06 MY MYPI2014000020A patent/MY165099A/en unknown
- 2012-07-06 ES ES12735503.0T patent/ES2547110T3/es active Active
- 2012-07-06 JP JP2014517831A patent/JP5913586B2/ja active Active
- 2012-07-06 BR BR112014000078A patent/BR112014000078A2/pt not_active IP Right Cessation
- 2012-07-06 MX MX2014000033A patent/MX369847B/es active IP Right Grant
- 2012-07-06 AU AU2012280208A patent/AU2012280208B2/en not_active Ceased
-
2014
- 2014-01-02 IL IL230313A patent/IL230313A/en not_active IP Right Cessation
- 2014-06-13 HK HK14105589.0A patent/HK1192237A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2841229A1 (en) | 2013-01-10 |
| US8735402B2 (en) | 2014-05-27 |
| US20130023545A1 (en) | 2013-01-24 |
| EP2729475A1 (de) | 2014-05-14 |
| JP2014518249A (ja) | 2014-07-28 |
| CA2841229C (en) | 2019-07-30 |
| WO2013004828A1 (de) | 2013-01-10 |
| RU2014104233A (ru) | 2015-08-20 |
| IL230313A (en) | 2016-08-31 |
| ES2547110T3 (es) | 2015-10-01 |
| AU2012280208A1 (en) | 2014-02-06 |
| CN103797015A (zh) | 2014-05-14 |
| MX369847B (es) | 2019-11-25 |
| DK2729475T3 (en) | 2015-09-21 |
| AU2012280208B2 (en) | 2016-07-21 |
| MX2014000033A (es) | 2014-02-17 |
| KR20140061386A (ko) | 2014-05-21 |
| EP2729475B1 (de) | 2015-06-10 |
| BR112014000078A2 (pt) | 2016-10-18 |
| EP2729475B8 (de) | 2015-08-26 |
| RU2609003C2 (ru) | 2017-01-30 |
| MY165099A (en) | 2018-02-28 |
| HK1192237A1 (en) | 2014-08-15 |
| CN103797015B (zh) | 2015-12-09 |
| JP5913586B2 (ja) | 2016-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL234485A (en) | Compounds based on imidazo [2,1 – b] pyridazine | |
| PH12013501402A1 (en) | Mesoionic Pyrido [1,2 -A] Pyrimidine Pesticides | |
| EP2608669A4 (en) | NEW PYRAZOLO- [1,5-A-] PYRIMIDINE DERIVATIVES AS ANTI-MTOR HEMMER | |
| IL243092B (en) | New triazolo[d–4,5]pyrimidine histories | |
| SG11201402197UA (en) | [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 | |
| AP3709A (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts | |
| IL225622A0 (en) | Furo[3, 2-di]pyrimidine compounds | |
| IL227496B (en) | Pyrazolo[4,3–b]pyridines are converted as drugs | |
| ZA201403441B (en) | [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid | |
| ZA201406323B (en) | Triazolo[4,5-d]pyrimidine derivatives | |
| EP2739627A4 (en) | 2,3-DIHYDROIMIDAZO [1,2-C] PYRIMIDIN-5 (1H) -ONE COMPOUNDS AND USE AS INHIBITORS OF LP-PLA2 | |
| IL229993A (en) | 8 - Alkoxy [1,2,4] triazolo [5,1 – c] pyrimidine– 2 | |
| IL221479A0 (en) | Triazolo [4,5-b] pyridin derivatives | |
| PT2694513E (pt) | Derivados de pirazolopirimidina | |
| ZA201307511B (en) | Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses | |
| HK1192240A1 (en) | Carboxylic acid derivatives with an oxazolo[5,4-d]pyrimidine ring [54-d] | |
| HK1185882A1 (en) | Pyrazino[2,3-d]isoxazole derivative [23-d] | |
| BR112013013282A2 (pt) | compostos de oxazolo[5,4-b]piridin-5-ila | |
| HK1192239A1 (zh) | 具有噁唑並 吡啶環的羧酸衍生物 | |
| HK1192237A1 (en) | Carboxylic acid derivatives with an oxazolo[5,4-d]pyrimidine ring [54-d] | |
| PL390846A1 (pl) | Pochodne 5,11-dimetylo-5H-indolo[2,3-b]chinoliny |